1982 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Patrizia Dell'Orto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial

Denkert, C., Budczies, J., Regan, M. M., Loibl, S., Dell’Orto, P., von Minckwitz, G., Mastropasqua, M. G., Solbach, C., Thürlimann, B., Mehta, K., Blohmer, J. U., Colleoni, M., Müller, V., Klauschen, F., Ataseven, B., Engels, K., Kammler, R., Pfitzner, B. M., Dietel, M., Fasching, P. A. & 1 others, Viale, G., Aug 15 2019, In : Breast Cancer Research and Treatment. 176, 3, p. 557-568 12 p.

Research output: Contribution to journalArticle

  • Ki-67 (30-9) scoring and differentiation of Luminal A- and Luminal B-like breast cancer subtypes

    Viale, G., Hanlon Newell, A. E., Walker, E., Harlow, G., Bai, I., Russo, L., Dell’Orto, P. & Maisonneuve, P., Nov 1 2019, In : Breast Cancer Research and Treatment. 178, 2, p. 451-458 8 p.

    Research output: Contribution to journalArticle

    Open Access
  • Association of Somatic Driver Alterations with Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical Trial

    Luen, S. J., Asher, R., Lee, C. K., Savas, P., Kammler, R., Dell'Orto, P., Biasi, O. M., Demanse, D., Jebailey, L., Dolan, S., Hackl, W., Thuerlimann, B., Viale, G., Colleoni, M., Regan, M. M. & Loi, S., Oct 1 2018, In : JAMA oncology. 4, 10, p. 1335-1343 9 p.

    Research output: Contribution to journalArticle

  • Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    International Breast Cancer Study Group Trial 23-01, Oct 1 2018, In : The Lancet Oncology. 19, 10, p. 1385-1393 9 p.

    Research output: Contribution to journalArticle

  • Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

    Viale, G., de Snoo, F. A., Slaets, L., Bogaerts, J., van ’t Veer, L., Rutgers, E. J., Piccart-Gebhart, M. J., Stork-Sloots, L., Glas, A., Russo, L., Dell’Orto, P., Tryfonidis, K., Litière, S., Cardoso, F. & for the MINDACT investigators, Jan 1 2018, In : Breast Cancer Research and Treatment. 167, 1, p. 123-131 9 p.

    Research output: Contribution to journalArticle